Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis - PubMed (original) (raw)

Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis

Daniel De Backer et al. Crit Care Med. 2006 Jul.

Abstract

Objective: Microvascular alterations may play an important role in the development of sepsis-induced organ dysfunction. Drotrecogin alfa activated (DAA) improves outcome in patients with severe sepsis, but its precise mechanism of action is not entirely defined. We investigated whether DAA can influence microcirculatory alterations in patients with severe sepsis.

Design: Prospective, nonrandomized study.

Setting: A 31-bed, medico-surgical intensive care unit of a university hospital.

Patients: Forty adult patients with severe sepsis who met the EU criteria for DAA administration.

Interventions: Twenty patients received the drug (DAA) and 20 had a contraindication to DAA administration (control).

Measurements and main results: An orthogonal polarization spectral imaging technique was used to visualize the sublingual microcirculation. In all patients, measurements were obtained at baseline, 4 hrs later, and then every 24 hrs for up to 7 days. In patients receiving DAA, measurements were also obtained just before and 4 hrs after the end of DAA infusion. The two groups were well matched for severity of disease, number of failing organs, and the degree of microvascular alterations at baseline. The proportion of perfused capillaries increased in the DAA treated patients already at 4 hrs (from 64% [51-80%] to 84% [71-88%], p < .01) but not in the control group (from 67% [59-76%] to 68% [61-71%], p = not significant). Microvascular perfusion decreased transiently at the end of DAA infusion. The improvement in microvascular blood flow was associated with a more rapid resolution of hyperlactatemia.

Conclusions: DAA administration rapidly improves sepsis-induced microvascular alterations, whereas its cessation is associated with a transient deterioration.

PubMed Disclaimer

Cited by

Retinal arterial blood flow and retinal changes in patients with sepsis: preliminary study using fluorescein angiography.
Erikson K, Liisanantti JH, Hautala N, Koskenkari J, Kamakura R, Herzig KH, Syrjälä H, Ala-Kokko TI. Erikson K, et al. Crit Care. 2017 Apr 10;21(1):86. doi: 10.1186/s13054-017-1676-3. Crit Care. 2017. PMID: 28395665 Free PMC article.
Point-of-care assessment of microvascular blood flow in critically ill patients.
Arnold RC, Parrillo JE, Phillip Dellinger R, Chansky ME, Shapiro NI, Lundy DJ, Trzeciak S, Hollenberg SM. Arnold RC, et al. Intensive Care Med. 2009 Oct;35(10):1761-6. doi: 10.1007/s00134-009-1517-1. Epub 2009 Jun 24. Intensive Care Med. 2009. PMID: 19554307
Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock.
Nguyen HB, Loomba M, Yang JJ, Jacobsen G, Shah K, Otero RM, Suarez A, Parekh H, Jaehne A, Rivers EP. Nguyen HB, et al. J Inflamm (Lond). 2010 Jan 28;7:6. doi: 10.1186/1476-9255-7-6. J Inflamm (Lond). 2010. PMID: 20181046 Free PMC article.
Benefit-risk assessment of drotrecogin alfa (activated) in the treatment of sepsis.
De Backer D. De Backer D. Drug Saf. 2007;30(11):995-1010. doi: 10.2165/00002018-200730110-00002. Drug Saf. 2007. PMID: 17973539 Review.
Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock.
De Backer D, Orbegozo Cortes D, Donadello K, Vincent JL. De Backer D, et al. Virulence. 2014 Jan 1;5(1):73-9. doi: 10.4161/viru.26482. Epub 2013 Sep 25. Virulence. 2014. PMID: 24067428 Free PMC article. Review.

Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis - PubMed (original) (raw)